SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices reach new all-time highs, fueled by economic uncertainty and speculation around central bank policies. The community is debating whether this rally is sustainable or indicative of a larger global financial shift, with some pointing to potential overbought conditions while others highlight ongoing global demand. Discussions also involve gold's role as a safe haven asset amidst concerns about the dollar and potential market corrections.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending downwards as the community discusses a potential offering and overall sector weakness. Some traders are pointing to the company's fundamentals and CEO stock sales as reasons for concern, while others anticipate a bounce. Discussions revolve around shorting opportunities and potential price targets amidst high volatility in the quantum computing sector.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors discuss potential trade setups and debate the stock's current valuation relative to its peers and future earnings potential. Community sentiment appears mixed, with some anticipating a breakout while others foresee a pullback, especially with earnings around the corner. Discussions also include Amazon's AI initiatives and their impact on AWS growth.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA ($NVDA) is trending amid discussions about its valuation, potential pullbacks, and technical analysis patterns, including head and shoulders formations and Fibonacci levels for intraday trading. Community members are weighing factors like high margin debt, AI bubble concerns, and upcoming earnings, while also keeping an eye on competitor AMD and potential government impacts.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the stock is struggling to hold above the $300 support level, leading to community discussions about its correlation to Bitcoin's price movements and potential downside risks. Some traders are expressing frustration with the stock's performance compared to miners and Bitcoin ETFs, while others speculate about potential catalysts like S&P 500 inclusion or a Bitcoin rally. The community is actively debating whether this dip presents a buying opportunity or signals further declines.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is experiencing volatility, with community members debating its role as a hedge against traditional assets like gold, which is currently seeing gains. Discussions include potential market manipulation and the impact of external factors such as political announcements and trade tensions. Some traders are anticipating a continued downturn, while others see current levels as a buying opportunity before a potential rebound.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing increased volatility amid concerns about credit quality and regional banks, sparking fears reminiscent of the 2008 financial crisis. Community members are closely watching gold's surge as a potential safe haven and debating the impact of a potential China trade war. Additionally, a highly anticipated announcement added to market uncertainty, with some expressing disappointment over its content.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

Bitfarms is trending due to a proposed offering of convertible senior notes, sparking mixed reactions within the community. While some express concern over potential dilution, others view it as a strategic move for long-term growth and expansion into AI and high-performance data centers, especially with comparisons to similar moves by sector peers. The community is actively debating the implications of the offering and its effect on the stock's future trajectory.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending amid mixed sentiment regarding its future, as investors debate the impact of its recently approved drug, Tonmya, and its commercial potential. While some see the current low price as a buying opportunity due to the company trading near its cash value, others express concerns about management and potential dilution, pointing to the stock's historical performance. The community is closely watching for updates on the drug's launch and potential partnerships.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines ($PRAX) is trending due to positive Phase 3 trial results for their essential tremor treatment, leading to significant price movement and analyst upgrades. The community is actively discussing a potential public offering and its impact on the stock's valuation, with some anticipating a drop while others believe the news is already priced in. Short sellers are facing pressure as the stock experiences a squeeze, with institutional ownership playing a significant role in the volatile trading.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  Arbutus Biopharma (ABUS) This Year?

Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?

Here is how Novartis (NVS) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?

Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

Here is how Aquestive Therapeutics (AQST) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?

Cramer+apos;s Lightning Round: Arbutus Biopharma is +apos;the ultimate spec+apos;

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...

Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value

Whitefort Capital Management, LP (together with its affiliates, Whitefort Capital, us or we), which is a long-term investor and the second largest shareholder of Arbutus Biopharma Corp. (NASDAQ...

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$4.51
Prev Close	$4.47
Open	$4.50
Dividend Yield	0.00%
50-Day Moving Average	$4.04
Beta	0.86
Avg. Volume	1.59M
PE Ratio	-15.64

52-Week High	$5.10
52-Week Low	$2.71
Market Capitalization	$856.89M
EPS (Annual)	-$0.3767
Price to Book	10.32
Revenue Per Employee	$140,250.00
Enterprise Value/EBITDA	N/A

ABUS
Arbutus Biopharma Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABUS News

ABUSArbutus Biopharma Corp